American Journal of Cardiology
Volume 103, Issue 12 , Pages 1727-1731 , 15 June 2009

Serum C-Reactive Protein and Risk of Cardiovascular Events in Middle-Aged and Older Chinese Population

  • Shan Jiang, MM

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Yuqian Bao, MD

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Xuhong Hou, MS

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Qichen Fang, PhD

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Chen Wang, PhD, MD

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Jiemin Pan, MD

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Yuhua Zuo, MD

      Affiliations

    • Caoyang Health Center, Shanghai, China
    • ,
  • Wenhong Zhong, MD

      Affiliations

    • Huayang Health Center, Shanghai, China
    • ,
  • Kunsan Xiang, MD

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • ,
  • Weiping Jia, MD, PhD

      Affiliations

    • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai, China
    • Corresponding Author InformationCorresponding author: Tel: 8621-6436-9181-8922; fax: 8621-6436-8031

Received 18 November 2008 ,Revised 10 February 2009 ,Accepted 10 February 2009.

References 

  1. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92:17K–22K
  2. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension. 2004;44:6–11
  3. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003;107:391–397
  4. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation. 2004;110:380–385
  5. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207
  6. Centers for Disease Control/American Heart Association. Workshop on Inflammatory Markers, and Cardiovascular Disease: Application to Clinical and Public Health Care Practice: Atlanta, March 14 to 15. Atlanta: Centers for Disease Control and Prevention; 2002;
  7. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511
  8. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004;93:1238–1242
  9. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46:464–469
  10. Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis. 2007;194:238–244
  11. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol. 2007;49:1798–1805
  12. Bao YQ, Jia WP, Chen L, Lu JX, Xiang KS. Association between C-reactive protein level and metabolic syndrome and components thereof. Zhonghua Yi Xue Za Zhi. 2006;86:2105–2109
  13. Cao Y, DiGiacomo M, Du HY, Ollerton E, Davidson P. Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice. J Cardiovasc Nurs. 2008;23:386–394
  14. Jiang B, Wang WZ, Chen H, Hong Z, Yang QD, Wu SP, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke. 2006;37:63–68
  15. Jia WP, Xiang KS, Chen L, Lu JX, Wu YM. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev. 2002;3:157–165
  16. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, Lu HJ, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia. 2007;50:286–292
  17. Dhingra R, Gona P, Nam BH, D'Agostino RB, Wilson PW, Benjamin EJ, et al. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med. 2007;120:1054–1062
  18. Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases—report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15:83–96
  19. Truelsen T, Mähönen M, Tolonen H, Asplund K, Bonita R, Vanuzzo D WHO MONICA Project. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke. 2003;34:1346–1352
  20. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, et al. Sino-MONICA Project: a collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring. Circulation. 2001;103:462–468
  21. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol. 2006;48:2235–2242
  22. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol. 2008;28:1385–1391

 This work was supported by the Key Project from Science and Technology Commission of Shanghai Municipality, Shanghai, China, Grant 04DZ19501; Scientific Research Program of Shanghai Municipal Education Commission, Shanghai, China, Grant 06BZ061; and National Basic Research Program of China (973 Program), The Ministry of Science and Technology of the People's Republic of China, Beijing, China, Grant 2006CB503901.

PII: S0002-9149(09)00609-2

doi: 10.1016/j.amjcard.2009.02.028

American Journal of Cardiology
Volume 103, Issue 12 , Pages 1727-1731 , 15 June 2009

Article Tools

* Image Usage & Resolution